Metoprolol Succinate Capsule, Extended Release
NDC Package 63304-009-30
Package Information
Metoprolol Succinate capsules is a medication a beta-blocker used to treat chest pain (angina), heart failure, and high blood pressure. This formulation utilizes a capsule, extended release delivery system. Marketed by Sun Pharmaceutical Industries Inc., this product is identified by NDC 63304-009 and is authorized under FDA application NDA210428.
Identification & Billing
- RxCUI: 1999031 - metoprolol succinate 100 MG 24HR Extended Release Oral Capsule
- RxCUI: 1999031 - 24 HR metoprolol succinate 100 MG Extended Release Oral Capsule
- RxCUI: 1999031 - metoprolol succinate 100 MG 24 HR Extended Release Oral Capsule
- RxCUI: 1999033 - metoprolol succinate 200 MG 24HR Extended Release Oral Capsule
- RxCUI: 1999033 - 24 HR metoprolol succinate 200 MG Extended Release Oral Capsule
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 63304 - Sun Pharmaceutical Industries Inc.
- 63304-009 - Metoprolol Succinate
- 63304-009-30 - 30 CAPSULE, EXTENDED RELEASE in 1 BOTTLE
- 63304-009 - Metoprolol Succinate
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 63304-009-30 identifies a specific commercial package of 30 capsule, extended release in 1 bottle of Metoprolol Succinate, a human prescription drug labeled by Sun Pharmaceutical Industries Inc.. This capsule, extended release is formulated for oral use and contains metoprolol succinate as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Sun Pharmaceutical Industries Inc. on February 07, 2018. The current certification is valid through December 31, 2026.
What are the primary indications for this medication?
This medication is a beta-blocker used to treat chest pain (angina), heart failure, and high blood pressure. Lowering high blood pressure helps prevent strokes, heart attacks, and kidney problems. This drug works by blocking the action of certain natural chemicals in your body (such as epinephrine) that affect the heart and blood vessels. This lowers heart rate, blood pressure, and strain on the heart.
How is this Sun Pharmaceutical Industries Inc. product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 63304000930. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.